| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a3c9e4b62f85cb66e1e0202c3204bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e335dd7c7643b3480e5a7fb5222b9825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5455c445a60455fce2aff1838edce04c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ab603cc2d3fc0f18263d8269a1ff691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d39622c1bb505bfdf659a1ad26df9a6 |
| publicationDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017150686-A1 |
| titleOfInvention |
Composition used to improve symptoms of autism spectrum disorder, and method using same for improving symptoms of autism spectrum disorder |
| abstract |
The present invention provides a composition that is effective in improving the symptoms of autism spectrum disorder. The composition is characterized in containing, as an active ingredient, at least one type of pyridoxamine compound selected from the group consisting of pyridoxamine and a pharmaceutically acceptable salt thereof. The composition can also be used in combination with at least one type of thiamine compound selected from the group consisting of thiamine, a derivative thereof, and a pharmaceutically acceptable salt thereof. |
| priorityDate |
2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |